CYCC - Cyclacel Pharmaceuticals GAAP EPS of -$6.23 misses by $0.34
2024-03-19 16:15:29 ET
More on Cyclacel Pharmaceuticals
- Cyclacel Pharmaceuticals receives $2.9M R&D tax credit
- Cyclacel Pharmaceuticals announces registered direct and private placement offering
- Seeking Alpha’s Quant Rating on Cyclacel Pharmaceuticals
- Historical earnings data for Cyclacel Pharmaceuticals
- Financial information for Cyclacel Pharmaceuticals